Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Hepatovirus
IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation.
Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users.
South Africa
The promise of CCR5 antagonists as new therapies for HIV-1.
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The promise of CCR5 antagonists as new therapies for HIV-1.
Repik A, Richards KH, Clapham PR. The promise of CCR5 antagonists as new therapies for HIV-1. Curr Opin Investig Drugs. 2007 Feb; 8(2):130-9.
View in:
PubMed
subject areas
Animals
Anti-HIV Agents
CCR5 Receptor Antagonists
Drugs, Investigational
HIV Infections
HIV-1
Humans
Models, Biological
Molecular Structure
authors with profiles
Paul R Clapham PhD